Brossard, Canada

Borhane Annabi

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Borhane Annabi: Innovator in Cancer Treatment

Introduction

Borhane Annabi is a prominent inventor based in Brossard, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of peptide compounds. With a total of 3 patents, Annabi is recognized for his dedication to advancing medical science.

Latest Patents

One of Annabi's latest patents focuses on peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy. This patent discloses various peptide compounds and conjugate compounds, along with the processes, methods, and uses for treating cancer. The compounds can comprise specific formulas designed to enhance the efficacy of cancer treatments.

Career Highlights

Annabi has built a career centered around innovative research in the medical field. His work has been instrumental in developing new therapeutic approaches to combat cancer, showcasing his commitment to improving patient outcomes. His expertise in peptide chemistry has positioned him as a leading figure in cancer research.

Collaborations

Throughout his career, Annabi has collaborated with notable professionals in the field, including Richard Béliveau and Michel Demeule. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Borhane Annabi's contributions to cancer treatment through his innovative peptide compounds highlight his role as a key inventor in the medical field. His ongoing research continues to pave the way for new therapeutic options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…